Provided by Tiger Trade Technology Pte. Ltd.

Cue Biopharma, Inc.

25.57
+0.32001.27%
Post-market: 25.570.00000.00%19:30 EDT
Volume:157.04K
Turnover:4.00M
Market Cap:185.75M
PE:-0.87
High:25.92
Open:25.60
Low:24.67
Close:25.25
52wk High:45.50
52wk Low:4.97
Shares:7.26M
Float Shares:6.85M
Volume Ratio:0.67
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.4600
EPS(LYR):-8.4244
ROE:-1603.48%
ROA:-172.66%
PB:80.41
PE(LYR):-3.04

Loading ...

Mar 18, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 19, 2020

Major Issues Report

8-K - Current report
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 17, 2020

Major Issues Report

8-K - Current report
Aug 24, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

Major Issues Report

8-K - Current report
Jun 05, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 21, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership